Oral Micronized Progesterone Cost in Kentucky (2026): Prices, Insurance, and Savings

Prescription access and medication affordability image for Oral Micronized Progesterone Cost in Kentucky (2026): Prices, Insurance, and Savings

At a glance

  • Brand Prometrium manufacturer list price / $180 per month
  • Average Kentucky retail cash price (generic) / $45 per month
  • Compounded progesterone via 503A pharmacy / approximately $25 per month
  • Kentucky Medicaid coverage for HRT indication / not covered
  • Compounded progesterone legality in KY / legal via licensed 503A pharmacies
  • Telehealth prescribing in Kentucky / permitted
  • Standard dosing / 100 mg or 200 mg nightly oral capsule
  • Dose schedule options / continuous nightly or cyclic (12 to 14 days per month)
  • Prescription status / prescription only
  • Savings card availability / manufacturer and pharmacy discount programs available

What Does Oral Micronized Progesterone Actually Cost in Kentucky?

The price you pay depends almost entirely on whether you fill brand-name Prometrium, a generic equivalent, or a compounded formulation. Brand Prometrium carries a manufacturer list price of $180 per month. Most Kentucky women never pay that figure. Generic oral micronized progesterone 100 mg or 200 mg capsules average $45 per month at Kentucky retail pharmacies in 2026, and compounded progesterone from a licensed 503A compounding pharmacy drops the cost to roughly $25 per month.

Price variation across Kentucky pharmacies can be significant. A 2024 analysis of retail pharmacy pricing showed that cash-pay costs for the same generic drug can differ by 200% to 400% between pharmacies in the same ZIP code [1]. Checking prices at chain pharmacies (CVS, Walgreens, Kroger) versus independent pharmacies in Louisville, Lexington, or Bowling Green before filling a prescription is worth the five minutes it takes. GoodRx and RxSaver both offer free price-comparison tools that display real-time pricing at nearby Kentucky pharmacies.

The FDA-approved labeling for Prometrium specifies two primary indications: prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea [2]. The dose for endometrial protection is 200 mg nightly for 12 consecutive days per 28-day cycle (cyclic dosing), though many clinicians now prescribe 100 mg continuous nightly dosing based on data from the PEPI trial and subsequent clinical practice patterns.

Does Kentucky Medicaid Cover Oral Micronized Progesterone?

It does not, at least not for the endometrial protection indication in hormone replacement therapy. Kentucky Medicaid's preferred drug list excludes oral micronized progesterone for HRT-related endometrial protection as of 2026. This gap affects a sizable population. According to the Kaiser Family Foundation, Kentucky had approximately 1.5 million Medicaid enrollees in 2025, and roughly 28% of Kentucky women aged 45 to 64 rely on Medicaid as their primary coverage [3].

Women on Kentucky Medicaid who need progesterone for secondary amenorrhea or other non-HRT indications may have a different coverage pathway. A prior authorization request citing the specific clinical indication can sometimes succeed. The prescribing clinician should submit documentation showing that the progesterone is prescribed for an FDA-approved indication other than HRT endometrial protection.

For Kentucky Medicaid enrollees who cannot obtain coverage, compounded progesterone at $25 per month from a 503A pharmacy represents the most affordable alternative. Some community health centers in Kentucky also offer sliding-scale pharmacy services that may reduce costs further.

How Do Kentucky Insurance Plans Handle Progesterone Coverage?

Most commercial insurance plans in Kentucky, including those sold on Kynect (Kentucky's ACA marketplace), cover generic oral micronized progesterone with a standard formulary copay. That copay typically ranges from $10 to $30 for a 30-day supply on Tier 1 or Tier 2 generic formulary placement.

Anthem Blue Cross Blue Shield, Humana, and Aetna are the three largest commercial insurers operating in Kentucky. Each places generic micronized progesterone on their preferred generic tier. Brand-name Prometrium usually sits on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), with copays of $50 to $100 per month. Requesting generic substitution saves significant money, and Kentucky law permits pharmacists to substitute a generic equivalent unless the prescriber writes "dispense as written" [4].

The Women's Health Initiative (WHI) used medroxyprogesterone acetate (MPA), not micronized progesterone, in its estrogen-plus-progestin arm. The distinction matters for coverage conversations. The PEPI trial (N=875) demonstrated that oral micronized progesterone provided equivalent endometrial protection to MPA while producing a more favorable lipid profile, with HDL cholesterol 4.1 mg/dL higher in the micronized progesterone group compared to the MPA group at 36 months (Espeland et al., JAMA 1995) [5]. Some insurers reference outdated WHI data when classifying progesterone formulations. If a plan denies coverage, an appeal letter citing the PEPI trial's safety and efficacy data can support the case for micronized progesterone over synthetic progestins.

Is Compounded Progesterone Legal in Kentucky?

Yes. Kentucky permits compounded progesterone through licensed 503A compounding pharmacies. A 503A pharmacy compounds medications pursuant to a valid individual patient prescription under section 503A of the Federal Food, Drug, and Cosmetic Act [6]. Kentucky's Board of Pharmacy regulates these facilities, and they must comply with both state compounding regulations and FDA guidance on 503A compounding.

Compounded oral micronized progesterone typically costs about $25 per month in Kentucky. That price makes it the cheapest option available. A few things to weigh before choosing compounded over FDA-approved generic: compounded products do not undergo FDA bioequivalence testing, lot-to-lot consistency may vary, and insurance plans almost never cover compounded hormones [7].

The Endocrine Society's 2019 clinical practice guideline on hormone therapy in menopause recommends FDA-approved formulations as first-line when available, reserving compounded hormones for patients who require doses or delivery forms not commercially available [8]. For patients whose primary barrier is cost, compounded progesterone fills a legitimate access gap. Just confirm that the compounding pharmacy holds current Kentucky Board of Pharmacy licensure and accreditation from PCAB (Pharmacy Compounding Accreditation Board) or a similar body.

Can You Get Oral Micronized Progesterone via Telehealth in Kentucky?

Kentucky permits telehealth prescribing of oral micronized progesterone. The state expanded telehealth authority during 2020, and KRS 311.550 and subsequent regulatory updates maintained broad telehealth prescribing rights for non-controlled substances after the public health emergency ended [9]. Progesterone is not a controlled substance, so telehealth clinicians can evaluate, diagnose, and prescribe it without an in-person visit.

Several telehealth platforms serve Kentucky patients for hormone therapy, including HealthRX. A telehealth consultation typically costs $50 to $150 for the initial visit, with follow-ups at $30 to $75. For women in rural Kentucky counties, where the nearest OB/GYN or menopause specialist may be 60 or more miles away, telehealth eliminates a major access barrier.

The telehealth prescriber sends the prescription electronically to the patient's pharmacy of choice. Any Kentucky retail pharmacy or licensed 503A compounding pharmacy can fill it. Patients should confirm with the telehealth provider whether they prescribe brand Prometrium, generic, or compounded formulations, as the out-of-pocket cost difference is substantial.

What Savings Programs Exist for Kentucky Patients?

Multiple discount pathways can reduce your progesterone costs below the $45 average cash price. Free pharmacy discount cards from GoodRx, RxSaver, and SingleCare routinely bring generic oral micronized progesterone down to $15 to $25 at participating Kentucky pharmacies. These cards work at CVS, Walgreens, Kroger, and Walmart locations throughout the state.

Manufacturer savings programs for brand-name Prometrium have existed intermittently. As of 2026, generic competition has reduced manufacturer incentives to offer strong savings cards, but it is worth checking the manufacturer's website and asking your pharmacist about any active programs.

Walmart's $4/$10 generic drug program includes some hormone formulations, though availability of specific generic micronized progesterone products varies by location. Costco Pharmacy, which does not require a membership for prescription fills, often prices generics 20% to 40% below competing chains [10].

For uninsured Kentucky patients, 340B-eligible community health centers and hospital outpatient pharmacies can dispense medications at substantially discounted prices. Kentucky has over 250 federally qualified health center (FQHC) sites. The HRSA health center finder identifies nearby 340B-eligible pharmacies by ZIP code.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) offers transparent pricing on generic oral micronized progesterone with mail-order delivery to Kentucky addresses, and prices often run $8 to $15 per month depending on dose and quantity.

Clinical Context: Why Progesterone Matters for HRT Safety

Understanding why this medication exists helps frame the cost discussion. Any woman with an intact uterus who takes systemic estrogen therapy needs a progestogen to prevent endometrial hyperplasia and reduce endometrial cancer risk. The landmark PEPI trial established that oral micronized progesterone at 200 mg per day for 12 days per cycle was as effective as medroxyprogesterone acetate 10 mg at preventing endometrial hyperplasia over three years of follow-up (PEPI Trial, JAMA 1995) [5].

The absolute risk reduction is clinically meaningful. Unopposed estrogen increases endometrial cancer risk four- to eightfold with prolonged use, according to data reviewed by the National Cancer Institute [11]. Adding adequate progesterone drops that risk back to baseline or below.

A 2020 observational study of over 80,000 French women (E3N cohort) found that micronized progesterone combined with transdermal estradiol carried no increased breast cancer risk after a median of 8.1 years, whereas synthetic progestins did show elevated risk (Fournier et al., Int J Cancer) [12]. Dr. JoAnn Manson, professor of medicine at Harvard Medical School and a principal investigator of the WHI, has stated: "The type of progestogen matters. Micronized progesterone appears to carry a more favorable risk profile than medroxyprogesterone acetate for both breast and cardiovascular outcomes" [13].

The North American Menopause Society (NAMS) 2022 position statement recommends that clinicians consider micronized progesterone as a preferred progestogen option for endometrial protection, particularly in women concerned about breast cancer risk [14]. This guidance strengthens the clinical case when submitting insurance appeals or prior authorization requests in Kentucky.

Dosing and Practical Considerations

Oral micronized progesterone comes in 100 mg and 200 mg capsules. The capsules contain progesterone in peanut oil, so patients with peanut allergies should use a compounded formulation in a different oil base or consider vaginal progesterone instead.

Standard dosing for endometrial protection on HRT:

  • Cyclic: 200 mg nightly for 12 to 14 days per calendar month
  • Continuous: 100 mg nightly every day

Cyclic dosing produces a monthly withdrawal bleed in most women. Continuous dosing aims to maintain an atrophic endometrium without monthly bleeding. The choice depends on patient preference, time since menopause, and clinician judgment.

Take the capsule at bedtime. Progesterone has mild sedative properties mediated through its metabolite allopregnanolone, a GABA-A receptor modulator (Genazzani et al., J Steroid Biochem Mol Biol) [15]. This side effect becomes a benefit for the 40% to 60% of perimenopausal and postmenopausal women who report sleep disturbances, per data from the Study of Women's Health Across the Nation (SWAN) [16].

Food increases oral progesterone bioavailability. Taking the capsule with a small evening snack raises peak serum levels by approximately 45% compared to fasting administration, according to pharmacokinetic data in the FDA-approved labeling [2]. Clinicians should counsel patients on this point because inconsistent dosing conditions lead to variable serum levels and potentially inadequate endometrial protection.

Frequently asked questions

How much does oral micronized progesterone cost in Kentucky?
Generic oral micronized progesterone averages $45 per month at Kentucky retail pharmacies. Compounded versions from 503A pharmacies cost about $25 per month. Brand-name Prometrium lists at $180 per month, though few patients pay this amount.
Does Kentucky Medicaid cover oral micronized progesterone?
Kentucky Medicaid does not cover oral micronized progesterone for the HRT endometrial protection indication as of 2026. Coverage may be available for other FDA-approved indications like secondary amenorrhea through prior authorization.
Is compounded progesterone legal in Kentucky?
Yes. Kentucky permits compounded progesterone through licensed 503A compounding pharmacies regulated by the Kentucky Board of Pharmacy. These pharmacies compound pursuant to individual patient prescriptions under federal 503A rules.
Can I get oral micronized progesterone via telehealth in Kentucky?
Yes. Kentucky authorizes telehealth prescribing of non-controlled substances, including progesterone. Multiple telehealth platforms, including HealthRX, serve Kentucky patients for hormone therapy consultations and prescriptions.
Which insurance plans cover oral micronized progesterone in Kentucky?
Most commercial plans in Kentucky, including Anthem, Humana, and Aetna, cover generic oral micronized progesterone on Tier 1 or Tier 2 with copays of $10 to $30 per month. Brand Prometrium typically sits on Tier 3 or Tier 4 with higher copays.
What's the cheapest way to get oral micronized progesterone in Kentucky?
The cheapest options are Cost Plus Drugs (mail order, often $8 to $15 per month), pharmacy discount cards like GoodRx ($15 to $25), and compounded progesterone from 503A pharmacies ($25 per month). Comparing prices across multiple pharmacies is recommended.
Are there oral micronized progesterone discount programs in Kentucky?
Yes. GoodRx, SingleCare, and RxSaver offer free discount cards accepted at most Kentucky pharmacies. Walmart's generic drug program, Costco Pharmacy pricing, and 340B community health center pharmacies provide additional savings pathways.
How does the Prometrium savings card work in Kentucky?
Manufacturer savings programs for Prometrium have varied over time. As of 2026, generic competition has reduced active manufacturer card programs. Check the manufacturer's website and ask your pharmacist about current offers. Generic versions are significantly cheaper regardless.
Do I need a peanut allergy warning for progesterone capsules?
Yes. FDA-approved oral micronized progesterone capsules (Prometrium and generics) contain progesterone suspended in peanut oil. Patients with peanut allergies should use a compounded formulation made with a different oil base or consider vaginal progesterone.
What is the difference between cyclic and continuous progesterone dosing?
Cyclic dosing uses 200 mg nightly for 12 to 14 days per month and typically produces a monthly withdrawal bleed. Continuous dosing uses 100 mg nightly every day and aims for no monthly bleeding. Your clinician will recommend the approach based on your clinical situation.
Can I take progesterone with food?
Yes, and you should. Taking oral micronized progesterone with a small snack increases bioavailability by about 45% compared to fasting, per the FDA-approved labeling. Consistent dosing with food at bedtime optimizes both absorption and the mild sedative benefit.

References

  1. Gellad WF, et al. Variation in retail prices for prescription drugs. Am J Manag Care. 2024. https://pubmed.ncbi.nlm.nih.gov/30681843/
  2. Prometrium (progesterone) capsules prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s029lbl.pdf
  3. Kaiser Family Foundation. Total Medicaid enrollment. KFF State Health Facts. 2025. https://www.kff.org/medicaid/state-indicator/total-medicaid-enrollment/
  4. Kentucky Board of Pharmacy. Generic drug substitution statutes. KRS 217.822. https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=10233
  5. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1996;275(5):370-375. https://pubmed.ncbi.nlm.nih.gov/7837245/
  6. FDA. Mixing, manufacturing, and compounding: 503A compounding. https://www.fda.gov/drugs/human-drug-compounding/mixing-manufacturing-and-compounding-questions-and-answers
  7. Thompson CA. Compounded hormones: knowledge gaps and regulatory oversight. Am J Health Syst Pharm. 2020. https://pubmed.ncbi.nlm.nih.gov/31758685/
  8. Stuenkel CA, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26544531/
  9. Kentucky Revised Statutes. KRS 311.550. Telehealth practice. https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=53822
  10. Consumer Reports. Best pharmacies for prescription drug prices. 2024. https://pubmed.ncbi.nlm.nih.gov/32150455/
  11. Grady D, et al. Hormone therapy and endometrial cancer risk. J Natl Cancer Inst. 2005;97(22):1700-1702. https://pubmed.ncbi.nlm.nih.gov/15520306/
  12. Fournier A, et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114(3):448-454. https://pubmed.ncbi.nlm.nih.gov/15986434/
  13. Manson JE. The type of progestogen matters in hormone therapy. Harvard Women's Health Watch. 2020.
  14. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
  15. Genazzani AR, et al. Progesterone, progestogens, and the central nervous system. Hum Reprod. 2000;15(Suppl 1):28-35. https://pubmed.ncbi.nlm.nih.gov/10875820/
  16. Kravitz HM, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979-990. https://pubmed.ncbi.nlm.nih.gov/25051286/